Medication info

JW Ibuprofen Premix Injection

Prescription medicationInjections
Ingredient · strength
Ibuprofen›400mg / 104mL
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
Injection packed in a polypropylene, multilayer film plastic container as a clear colorless to pale yellow liquid
Packaging
104 milliliters/vial, 208 milliliters/vial
Approval status
Active

MFDS item code 202500806 · Approved 2025.04.07

Summary

Main use
Adjunctive therapy to opioid analgesics for moderate to severe pain; reduction of fever
Who uses it
Adults · Children
Adult dosage
Administer this medicine at the minimum effective dose that meets each patient's treatment goals for the shortest possible period. After the initial dose, adjust the dose and frequency of administration as appropriate according to the patient's condition. This medicine is a premixed preparation and must be administered undiluted. Use only when one package unit per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for partial use. Adults may receive up to 3200mg daily. To reduce the risk of renal adverse reactions, ensure that patients are adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg may be administered daily. The infusion time must be at least 30 minutes. (2) Fever reduction Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may be administered every 4 hours after an initial dose of 400mg. Up to 3200mg may be administered daily. The infusion time must be at least 30 minutes. Before administration, visually inspect the injection for particulate matter or discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.
Children's dosage
6 months to under 12 years: Administer 10mg/kg per dose (maximum 400mg) intravenously every 4~6 hours as needed; the infusion time must be at least 10 minutes. Up to 40mg/kg or 2,400mg daily may be administered (whichever is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the infusion time must be at least 10 minutes. Up to 2,400mg may be administered daily.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunctive therapy to opioid analgesics for moderate to severe pain; reduction of fever

  • Moderate pain
  • severe pain
View approved original text

This medication aids in effectively managing pain ranging from moderate to severe and is prescribed as an adjunct therapy used in combination with narcotic analgesics. Additionally, it is used to alleviate discomfort through its antipyretic action when fever occurs, thereby helping to improve both pain and fever symptoms simultaneously.

Dosage and Administration

Adult dosage

Administer this medicine at the minimum effective dose that meets each patient's treatment goals for the shortest possible period. After the initial dose, adjust the dose and frequency of administration as appropriate according to the patient's condition. This medicine is a premixed preparation and must be administered undiluted. Use only when one package unit per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for partial use. Adults may receive up to 3200mg daily. To reduce the risk of renal adverse reactions, ensure that patients are adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg may be administered daily. The infusion time must be at least 30 minutes. (2) Fever reduction Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may be administered every 4 hours after an initial dose of 400mg. Up to 3200mg may be administered daily. The infusion time must be at least 30 minutes. Before administration, visually inspect the injection for particulate matter or discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.

Children's dosage

6 months to under 12 years: Administer 10mg/kg per dose (maximum 400mg) intravenously every 4~6 hours as needed; the infusion time must be at least 10 minutes. Up to 40mg/kg or 2,400mg daily may be administered (whichever is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed; the infusion time must be at least 10 minutes. Up to 2,400mg may be administered daily.

Precautions

This medication may increase the risk of serious cardiovascular issues such as myocardial infarction or stroke in patients with cardiovascular diseases or risk factors. Therefore, these patients should carefully monitor their symptoms while taking this medication and consult a healthcare professional immediately if any adverse reactions occur. This medication can cause serious gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforations; therefore, special caution is required for the elderly or long-term users. If symptoms such as abdominal pain, bloody stools, or vomiting occur while taking this medication, the physician should be notified immediately. Patients with a history of gastrointestinal ulcers or bleeding, or those with severe hepatic, renal, or cardiac dysfunction should not take this medication. Furthermore, patients allergic to any component of this medication or those with a history of asthma should also avoid use. Patients with hematological abnormalities or bleeding tendencies, cirrhosis, renal impairment, heart diseases, and hypertension should be especially cautious during administration. It is also advisable for pregnant and lactating women to avoid this medication. This medication can cause various side effects including serious allergic reactions, skin rashes, hepatic dysfunction, hematological abnormalities, renal impairment, and respiratory distress; if any of these symptoms appear, immediate consultation with healthcare professionals is necessary. This medication should not be taken in excess of the recommended dosage, and it is safer not to take it in conjunction with other nonsteroidal anti-inflammatory drugs. Especially in patients with hypertension, blood pressure may rise or worsen, so blood pressure should be frequently monitored during early use and throughout the course of treatment. Patients with fluid retention or edema may experience worsening of their condition while taking this medication; hence, caution is required. Patients with impaired renal or hepatic function should undergo regular evaluations while taking this medication, and if any abnormal findings are detected, the dosage should be adjusted or the medication should be discontinued. This medication can interact with aspirin or anticoagulants, ACE inhibitors, diuretics, lithium, and methotrexate; therefore, patients taking these medications must inform healthcare professionals and exercise caution during use. During pregnancy, especially in the third trimester, it may be harmful to the fetus, so this medication should not be used during pregnancy, and lactating women should discontinue breastfeeding or consult with healthcare professionals if taking this medication. The safety and efficacy of this medication have not been established in children under 6 months of age, so its use is not recommended in this age group. Elderly patients may have reduced physical function, thereby increasing the risk of side effects when taking this medication, which necessitates dosage adjustment and monitoring. In the case of overdose, severe symptoms such as dizziness, vomiting, abdominal pain, renal failure, respiratory distress, and hypotension may occur; thus, strict adherence to the dosage is necessary, and if an overdose occurs, immediate medical attention should be sought.

Side effects

  • shock
  • anaphylactic reaction
  • mimicry concerns
  • chills
  • respiratory distress
  • hypotension
  • decreased hematocrit
  • decreased hemoglobin
  • anemia
  • aplastic anemia
Show 138 more
  • hemolytic anemia
  • agranulocytosis
  • granulocytopenia
  • leukopenia
  • thrombocytopenia
  • impaired platelet function
  • eosinophilia
  • peptic ulcer
  • gastrointestinal ulcer
  • gastrointestinal bleeding
  • perforation
  • ulcerative colitis
  • bloody stools
  • gastritis
  • pancreatitis
  • hematemesis
  • Crohn's disease
  • loss of appetite
  • nausea
  • vomiting
  • abdominal pain
  • dyspepsia
  • diarrhea
  • discomfort in the upper abdomen
  • epigastric pain
  • thirst
  • stomatitis
  • abdominal distension
  • oral ulcer
  • constipation
  • melena
  • skin mucosal syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • photosensitivity reaction
  • drug rash
  • angioedema
  • vesicular dermatitis
  • erythema multiforme
  • papular rash
  • skin reddening
  • vesicles
  • rash
  • exfoliative dermatitis
  • acute generalized pustular psoriasis
  • hepatitis
  • jaundice
  • liver dysfunction
  • hepatic impairment
  • hypersensitivity
  • anaphylaxis
  • asthma attack
  • urticaria
  • eczema
  • purpura
  • rash
  • pruritus
  • asthma
  • bronchoconstriction
  • respiratory distress
  • wheezing
  • scotoma
  • hearing loss
  • tinnitus
  • dysgeusia
  • dizziness
  • drowsiness
  • lightheadedness
  • depression
  • headache
  • cerebrovascular accident
  • irritability
  • aseptic meningitis
  • meningitis
  • hypertension
  • palpitations
  • heart failure
  • myocardial infarction
  • angina
  • acute renal failure
  • oliguria
  • hematuria
  • proteinuria
  • increased serum creatinine
  • hyperkalemia
  • interstitial nephritis
  • nephrotic syndrome
  • renal papillary necrosis
  • decreased urine output
  • generalized edema
  • breathlessness
  • lethargy
  • Conn's syndrome
  • periorbital edema
  • facial edema
  • fatigue
  • fever
  • epistaxis
  • edema
  • peripheral edema
  • nausea
  • bloating
  • headache
  • hemolysis
  • drowsiness
  • peripheral edema
  • urinary disorders
  • anemia
  • decreased hemoglobin
  • dyspepsia
  • wound hemolysis
  • abdominal discomfort
  • cough
  • hypokalemia
  • eosinophilia
  • hypoalbuminemia
  • neutropenia
  • increased hematuria
  • hypernatremia
  • hypertension
  • hypoalbuminemia
  • hypotension
  • diarrhea
  • bacterial pneumonia
  • increased serum LDH
  • increased platelets
  • bacteremia
  • injection site pain
  • nausea
  • dizziness
  • abdominal pain
  • liver dysfunction
  • metabolic acidosis
  • loss of consciousness
  • seizures
  • renal failure
  • respiratory depression
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and safety.

Appearance and packaging

Appearance

Injection packed in a polypropylene, multilayer film plastic container as a clear colorless to pale yellow liquid

Package unit

104 milliliters/vial, 208 milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.